Patents Assigned to NTD LABS, S. L.
  • Use of a casein hydrolysate as an antiviral agent
    Patent number: 10772927
    Abstract: The present invention relates to the use of a casein hydrolysate as an antiviral agent for the treatment of opportunistic virus infections, especially herpesvirus and human papillomavirus. This casein hydrolysate has an application in both the therapeutic treatment of established symptoms and the prevention of the infection or the reactivation of a latent infection by an opportunistic virus. The casein hydrolysate of the present invention is effective for the prevention of opportunistic virus infections in individuals with weakened immune system.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: September 15, 2020
    Assignee: NTD Labs, S.L.
    Inventors: Pere Adell Winkler, Guillermo Lopez Zarco
  • Use of a casein hydrolysate as an antiherpetic agent
    Patent number: 9662369
    Abstract: The present invention relates to the use of a casein hydrolysate as an antiherpetic agent. This casein hydrolysate has an application in both the treatment and the prevention of the reactivation of a latent infection by a herpesvirus, and is effective both orally and topically. It also relates to a pharmaceutical composition in the form of cream, gel, ointment or paste for topical administration that contains it.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: May 30, 2017
    Assignee: NTD Labs, S.L.
    Inventors: Guillermo López Zarco, Pere Adell Winkler
  • USE OF A CASEIN HYDROLYSATE AS AN ANTIVIRAL AGENT
    Publication number: 20160361374
    Abstract: The present invention relates to the use of a casein hydrolysate as an antiviral agent for the treatment of opportunistic virus infections, especially herpesvirus and human papillomavirus. This casein hydrolysate has an application in both the therapeutic treatment of established symptoms and the prevention of the infection or the reactivation of a latent infection by an opportunistic virus. The casein hydrolysate of the present invention is effective for the prevention of opportunistic virus infections in individuals with weakened immune system.
    Type: Application
    Filed: February 17, 2015
    Publication date: December 15, 2016
    Applicant: NTD LABS, S. L.
    Inventors: Pere ADELL WINKLER, Guillermo LOPEZ ZARCO